Targeting the Tumor Microenvironment in R/M SCCHN

Condition:   Head and Neck Cancer
Interventions:   Drug: Avelumab;   Drug: CTX;   Radiation: RT
Sponsor:   Gruppo Oncologico del Nord-Ovest
Recruiting

http://bit.ly/2GxdJwa